Suchergebnisse - "Prevel, Renaud"

PubPharm (67)

21

Efficacy of carbapenem vs non carbapenem β-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum β-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study

enthalten in: Annals of intensive care | 2023

von Cariou, E. | Griffier, R. | Orieux, A. | +16

22

NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE

enthalten in: Europäisches Patentamt | 2023

von BERGER PATRICK | DUPIN ISABELLE | PREVEL RENAUD | +7

23

Neonatal imprinting of alveolar macrophages via neutrophil-derived 12-HETE

enthalten in: Nature | 2023

von Pernet, E. | Sun, S. | Sarden, N. | +17

24

Clinical trajectories and impact of acute kidney disease after acute kidney injury in the intensive care unit : a 5-year single-centre cohort study

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Orieux, A. | Prezelin-Reydit, M. | Prevel, R. | +4

25

New compositions and methods of treating COVID-19 disease

enthalten in: Europäisches Patentamt | 2022

von BERGER PATRICK | DUPIN ISABELLE | PREVEL RENAUD | +7

26

Gut bacteriobiota and mycobiota are both associated with Day-28 mortality among critically ill patients

enthalten in: Critical care (London, England) | 2022

von Prevel, R. | Enaud, R. | Orieux, A. | +5

27

Gut bacteriobiota and mycobiota are both associated with Day-28 mortality among critically ill patients

enthalten in: Critical care | 2022

von Prevel, R. | Enaud, R. | Orieux, A. | +5

28

Gut bacteriobiota and mycobiota are both associated with Day-28 mortality among critically ill patients

enthalten in: Critical care | 2022

von Prevel, R. | Enaud, R. | Orieux, A. | +5

29

Training can't always lead to Olympic macrophages

enthalten in: The Journal of clinical investigation | 2022

von Pernet, E. | Prevel, R. | Divangahi, M.

CommentOn: J Clin Invest. 2022 Apr 1;132(7):. - PMID 35133977

30

Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes

enthalten in: Journal of clinical medicine | 2022

von Prével, R. | Delmas, Y. | Guillotin, V. | +2